金吾财讯 | 维立志博-B(09887)今日起招股，拟发行3205.44万股H股，其中90%为国际发售；10%为香港发售，另有15%超额配股权。每股招股价介于31.6港元-35港元，每手100股，入场费3,535.30港元。摩根士丹利、中信证券为联席保荐人。股份预期将于7月25日挂牌上市。以中间价33.3港元计算，预期集资净额约9.68亿港元，拟将其中约65%将用于集团临床阶段候选药物正在进行及计划进行的临床开发及监管事务；约15%将用于推进集团的临床前资产、扩展集团的现有管线及优化集团的技术平台；约10%将主要用于提升集团的生产能力，其次用于候选药物获批销售后的商业化；及约10%将用于营运资金及一般企业用途。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.